Faculty profile

Christopher Bredeson

ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Christopher Bredeson

Researcher

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
27 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Access To Care Car-T Leukemia Point-Of-Care Biomanufacturing

Latest papers

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.
Transplantation and cellular therapy · 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.
Transplantation and cellular therapy · 2026
Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.
Transplantation and cellular therapy · 2026

All 81 publications

Latest funding

Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
CIHR · 2022 · Principal investigator
$3,216,843
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
CIHR · 2022 · Principal investigator
$804,211
Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
CIHR · 2021 · Co-investigator
$100,000

All 6 grants and awards

81 publications.

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.

Abduallah Y, Allan D, Atkins H, Bredeson C, Kekre N, Kennah M, Masurekar A, Thyagu S, Nampoothiri RV

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2026.09.001 PMID: 42700928

Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.

Masurekar AN, Burkett KM, Rahgozar A, Walter RB, Othus M, Abrol K, Mortezaagha P, Thyagu S, Nampoothiri RV, Kennah M, Kekre N, Giguere P, Abduallah Y, Atkins H, Cieniak C, Berardi P, Ramsay T, Mallick R, Carrier M, Bredeson C, Allan D

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2025.12.996 PMID: 41482160

Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.

Koo E, Prince C, Allan D, Atkins H, Bredeson C, Kekre N, Kennah M, Masurekar A, Thyagu S, Vasudevan Nampoothiri R

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2026.01.036 PMID: 41690552

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy

Buchan CA, Agbayani G, Hueniken K, Vijenthira A, Sebag M, Wang P, Hicks LK, Hay AE, Assouline S, Fraser G

Transplantation and Cellular Therapy20263 citations

DOI: 10.1016/j.jtct.2025.10.037

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Bhella S, Agbayani G, Hueniken K, Vijenthira A, Wilkin AM, Sebag M, Wang P, Hicks LK, Hay AE, Hosseini-Moghaddam SM

Blood advances2026

DOI: 10.1182/bloodadvances.2025018117

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Mozessohn L, Villeneuve PJA, Somé NH, Mercer RE, Masucci L, Kouroukis T, Bredeson C, Aktar S, Guan Q, Prica A

Current Oncology2026

DOI: 10.3390/curroncol33060366

Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (ATG) Based GVHD Prophylaxis.

Dhir V, Prince C, Allan D, Atkins H, Bredeson C, Kekre N, Kennah M, Masurekar A, Vasudevan Nampoothiri R

European journal of haematology2025

DOI: 10.1111/ejh.14380 PMID: 39757868

Radiotherapy for Isolated Breast Myeloid Sarcoma.

Bourque JM, Gaudet J, Manengue A, Bredeson C, Samant R

Journal of medical cases2025

DOI: 10.14740/jmc4334 PMID: 41030484

Assessing Clinical Impressions of Early Warning Score Integration With the Rapid Response Team: Protocol for a Prospective Cohort Study.

Tran A, Ramchandani R, Brehaut J, Hudek N, Haines J, Watpool I, Porteous R, Kusevic D, Bucciero K, Kyeremanteng K, Hartwick M, Thavorn K, Hooper J, Kubelik D, Herry C, Scales N, Hryciw B, Abou-Khalil J, Perry J, Bredeson C, Seely A

JMIR research protocols2025

DOI: 10.2196/65360 PMID: 40742731

Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Hickey CL, Zhang MJ, Allbee-Johnson M, Romee R, Majhail NS, Malki MMA, Antin JH, Benjamin CL, Bredeson C, Chhabra S, Grunwald MR, Inamoto Y, Kanakry CG, Milano F, Soiffer RJ, Solomon SR, Spellman SR, Brunstein CG, Cutler C

Transplantation and cellular therapy2025

DOI: 10.1016/j.jtct.2024.12.021 PMID: 39755256

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Access To Care Dear Professor Bredeson, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Christopher Bredeson

Research

Latest papers

Latest funding

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.

Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.

Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (ATG) Based GVHD Prophylaxis.

Radiotherapy for Isolated Breast Myeloid Sarcoma.

Assessing Clinical Impressions of Early Warning Score Integration With the Rapid Response Team: Protocol for a Prospective Cohort Study.

Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)

Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)

Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting

Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work

Platelet Transfusions in Hematopoietic Stem Cell Transplantation - The PATH Phase III Trial

Platelet Transfusions in Hematopoietic Stem cell Transplantation - The PATH Study

Frequent collaborators

David Allan

Mitchell Sabloff

Natasha Kekre

Lothar Huebsch

Harold Atkins

Jason Tay

Michael Kennah

Alan Tinmouth

Dean Fergusson

Dawn Maze

Antonio Giulivi

Arleigh McCurdy

Tom Kouroukis

Amaris Karin Balitsky

Alissa Visram

Michael Sebag

Brian Hutton

Curtis Cooper

Kednapa Thavorn

Kednapa Thavorn

Rajat Kumar

Timothy Ramsay

Alexandre Tran

Baldwin Toye

Juthaporn Cowan

Kwadwo Kyeremanteng

Stephen Betschel

Robert Smith

Tara Baetz

Michael Chu

Danielle Rodin

Natasha Kekre

Shelly Bolotin

Anand Ghanekar

Nazia Selzner

Lisa Hicks

Mark Cattral

Jamie Brehaut

Donna Reece

Amit Bar-Or